Semaglutide is the active pharmaceutical ingredient that has helped thousands of people lose and maintain weight loss in combination with diet and exercise
Key drivers fueling this momentum include a strong product pipeline with innovative molecules and combination therapies, and increased healthcare spending in emerging economies
Eating disorder treatment is about building a healthier and better relationship with food, Ihlenfeld said
Retatrutide offers a groundbreaking approach to weight loss, acting as a GGG tri-agonist by targeting GLP-1, GIP, and GCG hormone pathways
The reasons for this vary, but the limited mechanism of action may be one contributing factor
GLP-1s have become a popular topic because of their important role in appetite regulation, blood sugar balance, and overall metabolic health